News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
High response rates in poor-risk population – Hagop Kantarjian
Photo of Dr. Hagop Kantarjian from obroncology.com
Jul 22, 2023, 17:56

High response rates in poor-risk population – Hagop Kantarjian

Our study of aza + ven + pevonedistat NEDD8-activating enzyme inhibitor in secondary AML & MDS/CMML after HMA failure. High response rates in poor-risk population. Data from randomized ph3 study in AML are awaited.

For article: Click here

Source: Hagop Kantarjian/Twitter

cancer Hagop Kantarjian Leukemia OncoDaily Oncology pevonedistat Research
Special Coverage
Blog
May 10, 2025, 20:06
Zainab Shinkafi-Bagudu Honors UICC President Ulrika Årehed Kågström on Her Birthday
Blog
May 10, 2025, 19:24
Dato' Dr Saunthari Somasundaram: I had the privilege of speaking with Anita Abu Bakar on a topic close to both our hearts
Blog
May 10, 2025, 19:04
Elizabeth Ugwoma Awo-Ejeh: Mental stress is something we hardly talk about, yet it's something almost everyone carries
Insight
May 10, 2025, 18:11
Digestive Cancers Europe highlights Sara Ben Hmido’s study on patient perspectives of AI in surgical decision-making
Blog
May 10, 2025, 18:03
April Dorenbosch discussed migrant struggles with cancer care in Europe in Youth Cancer Europe interview
Insight
May 10, 2025, 17:56
David Planchard discussed EGFR-mutated NSCLC and clinical research developments with chinese colleagues
Blog
May 10, 2025, 17:48
Manette Le Grange Highlights ACT for Children Initiative in Pediatric Cancer Care
Blog
May 10, 2025, 17:44
Ashish Shah Explores Viral Mimicry Approach to Glioblastoma at Sylvester Comprehensive Cancer Center
Societies
May 10, 2025, 17:43
LUNGevity Foundation: Upal Basu Roy on progress in Small Cell Lung Cancer research
Science
May 10, 2025, 17:34
Galip Can Uyar: Prediction of 90-day Mortality Among Cancer Patients with Unplanned Hospitalisation
Insight
May 10, 2025, 17:23
Roupen Odabashian reflects on 2025 JAMA study evaluating AI-generated discharge summaries
Drugs
May 10, 2025, 17:11
A*STAR IMCB study led by Valerie Yang identified AZD5153 and Pazopanib drug combination for soft tissue sarcoma treatment